Article
Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine.
American journal of clinical pathology - 1 Jun 2012
Shi Chanjuan, Washington Kay
Abstract excerpt
Currently, molecular testing in colorectal cancer (CRC) is aimed at detecting Lynch syndrome and predicting response to anti-epidermal growth factor receptor (EGFR) therapies. However, CRC is a complex disease, with at least 3 molecular pathways of carcinogenesis. The importance of the EGFR signaling pathway in colorectal carcinogenesis is underscored by the availability of anti-EGFR monoclonal antibodies for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
